South East Angels Invests in Onya Therapeutics to Transform Wound Care

South East Angels Invests in Onya Therapeutics to Transform Wound Care with Cutting-Edge Biotech Solutions

South East Angels is pleased to announce its latest investment in Onya Therapeutics, a pioneering biotech startup focused on revolutionising wound care. This funding forms part of Onya’s £1.8 million Seed round, which also includes US-based angel investors.

By leveraging novel technologies, Onya Therapeutics aims to accelerate wound healing, enhance patient quality of life, and reduce antimicrobial resistance—addressing a critical need in chronic wound management. South East Angels is proud to support this innovative company as it moves closer to commercialising its advanced treatments.

Kristina Pereckaite, Managing Director at South East Angels, said:
“We’re pleased to be backing the Onya team. Dr. Rachael’s and Thomas’ expertise in the market is unparalleled, and we’re excited about the significant impact their innovation will have on the healthcare sector.”

Jake Fox, Syndicate Lead at South East Angels, added:
“We believe Onya Therapeutics is on track to make a real difference in wound care. Their technology pipeline stands out, and we’re thrilled to support them in developing solutions that offer clinicians and patients more effective, accessible options.”

Dr. Rachael McInnes, COO at Onya Therapeutics, said:
“This investment from South East Angels is a strong UK endorsement of our mission to transform wound care. We’re dedicated to delivering treatments that enable faster healing while reducing the burden on clinical resources and improving patients’ overall well-being.”

About Onya Therapeutics
Onya Therapeutics specialises in advanced wound care solutions, applying scientific, commercial, and clinical expertise to improve patient outcomes. Through novel technologies, the company aims to expedite healing, enhance quality of life, and reduce antimicrobial resistance.
Learn more at onyatherapeutics.com.